Phenominer Database Results (21 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Post Insult Time Unit Clinical Measurement Notes Record ID Study ID
ACI/SegHsd percentage of study population developing unilateral renal agenesis during a period of time control condition Shull JD, et al., Mamm Genome. 2006 Jul;17(7):751-9. Epub 2006 Jul 14. kidney integrity trait male 0 days 87 5.7 % necropsy 0.0 0 69374 1157
WM/Nem number of blastocysts implanted per litter control condition Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108. embryo implantation trait both -1 days 13 12.6 null necropsy 0.0 12 days 111260 3199
SD-Cftrem1Apb percentage of study population developing meconium ileus during a period of time control condition McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. intestine integrity trait not specified 7 days 0 16.0 % 0.0 necropsy 0.0 0 percentage of study population developing meconium ileus during a period of time (CMO:0003881) 111463 3184
ACI.COP-(D10Mgh8-D10Rat4)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11365 75
ACI.COP-(D3Rat130-D3Rat114)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11363 75
F344/Jcl percentage of study population developing unilateral renal agenesis during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. kidney integrity trait male 900 days 8 0.0 % necropsy 0.0 0 106884 341
ACI/SegHsd percentage of study population developing unilateral renal agenesis during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. kidney integrity trait male 900 days 12 24.0 % necropsy 0.0 0 106885 341
F344/Jcl percentage of study population developing subcutaneous tumors during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. hypodermis integrity trait male 900 days 8 38.0 % necropsy 0.0 0 CMO:0003387 percentage of study population developing subcutaneous tumors during a period of time 106886 341
ACI/SegHsd percentage of study population developing subcutaneous tumors during a period of time control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. hypodermis integrity trait male 900 days 12 0.0 % necropsy 0.0 0 CMO:0003387 percentage of study population developing subcutaneous tumors during a period of time 106887 341
WM/Nem number of blastocysts/embryos lost postimplantation to litter size ratio control condition Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108. embryo implantation trait both -1 days 13 13.0 % necropsy 0.0 12 days 111269 3199
ACI.COP-(D6Rat80-D6Rat146)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11359 75
BN/SsNHsd percentage of study population developing unilateral renal agenesis during a period of time control condition Shull JD, et al., Mamm Genome. 2006 Jul;17(7):751-9. Epub 2006 Jul 14. kidney integrity trait female 0 days 36 0.0 % necropsy 0.0 0 69373 1157
ACI.COP-(D3Mgh16-D3Rat119)/Shul mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 3 0.0 null necropsy 0 11361 75
COP/CrCrl mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 5 0.0 null necropsy 0 11369 75
SS.ZUC-Leprfa-/-/Slc ratio of survivors of metabolic syndrome to total study population during a period of time control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. total life span male 126 days 20 35.0 % necropsy 0.0 0 ratio of survivors of metabolic syndrome to total study population during a period of time (CMO:0003803) 101910 2642
BN/SsNHsd percentage of study population developing unilateral renal agenesis during a period of time control condition Shull JD, et al., Mamm Genome. 2006 Jul;17(7):751-9. Epub 2006 Jul 14. kidney integrity trait male 0 days 43 0.0 % necropsy 0.0 0 69375 1157
ACI/SegHsd mammary tumor number control condition Kurz SG, et al., Endocrinology. 2008 Apr 17 mammary gland integrity trait female 259 days 4 0.0 null necropsy 0 11367 75
ACI/SegHsd percentage of study population developing unilateral renal agenesis during a period of time control condition Shull JD, et al., Mamm Genome. 2006 Jul;17(7):751-9. Epub 2006 Jul 14. kidney integrity trait female 0 days 96 13.5 % necropsy 0.0 0 69372 1157
SS.ZUC-Leprfa+/+/Slc ratio of survivors of metabolic syndrome to total study population during a period of time control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. total life span male 126 days 6 100.0 % necropsy 0.0 0 ratio of survivors of metabolic syndrome to total study population during a period of time (CMO:0003803) 101909 2642
BDIX/Nem number of blastocysts/embryos lost postimplantation to litter size ratio control condition Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108. embryo implantation trait both -1 days 13 21.6 % necropsy 0.0 12 days 111275 3199
BDIX/Nem number of blastocysts implanted per litter control condition Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108. embryo implantation trait both -1 days 13 9.2 null necropsy 0.0 12 days 111266 3199